- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01366261
Rigid Versus Semirigid Thoracoscopy in Diagnosing Pleural Diseases: a Randomized Study
November 9, 2011 updated by: Aleš Rozman
The purpose of our study was to compare the size and the quality of biopsy samples together with the diagnostic adequacy of semirigid thoracoscopy with that of rigid instrument in prospective, randomized fashion.
The second aim was to compare safety and tolerability of both types of procedure, performed in local anesthesia with addition of intravenous sedation and analgesia.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
84
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Golnik
-
Golnik 36, Golnik, Slovenia, 4204
- University Clinic Golnik
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 or more years old
- unilateral pleural effusion of unknown origin
- pleural irregularities suspicious for pleural malignancy
- referral for thoracoscopy after less invasive means of diagnosis had failed
Exclusion Criteria:
- uncontrolled bleeding tendency
- unstable cardiovascular status
- severe heart failure
- ECOG performance status 4
- persistent hypoxemia after evacuation of pleural fluid
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: semirigid thoracoscopy
Semirigid instrument which we compare was autoclavable Olympus LTF-160 (Olympus Tokyo, Japan).
Handle and its controls were similar to flexible fiberoptic bronchoscope, with the insertion portion composed of 22 cm long rigid part and distal 5 cm flexible tip with angulation range 1600 up / 1300 down.
The external diameter of insertion portion was 7 mm with 2,8 mm inner channel diameter.
The instrument was compatible with Olympus EVIS Exera 160 and 145 and EVIS 100 and 140 video processors and light sources, otherwise employed in video-bronchoscopy.
Forceps, which we used was flexible FB-55CD-1 Olympus forceps with 5 mm long cusps and diameter, which fitted the diameter of inner channel of semirigid thoracoscope.
|
thoracoscopy with semirigid instrument
Other Names:
|
|
Active Comparator: rigid thoracoscopy
The rigid instrument was autoclavable OP EndoEYE WA50120A (Olympus Tokyo, Japan) video thoracoscope.
The length of the instrument was 29 cm with 00 direction of view and 700 field of view.
The external diameter of the instrument was 10 mm with 5,2 mm inner channel diameter.
The instrument was compatible with Olympus Visera OTV-S7V and EVIS Exera II CV-180 video processors.
Cusps of rigid forceps had outer diameter 5 mm and length 10 mm.
|
thoracoscopy with rigid instrument
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
diagnostic adequacy of semirigid thoracoscopy
Time Frame: 12 months
|
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
safety
Time Frame: 1 month
|
Major adverse events:
Minor adverse events:
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (Actual)
November 1, 2011
Study Completion (Actual)
November 1, 2011
Study Registration Dates
First Submitted
May 31, 2011
First Submitted That Met QC Criteria
June 3, 2011
First Posted (Estimate)
June 6, 2011
Study Record Updates
Last Update Posted (Estimate)
November 11, 2011
Last Update Submitted That Met QC Criteria
November 9, 2011
Last Verified
November 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- endo-0001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pleural Diseases
-
China-Japan Friendship HospitalNot yet recruiting
-
Assiut UniversityNot yet recruitingPleural Effusion | Exudative Pleural Effusion | Transudative Pleural Effusion
-
Ain Shams UniversityCompletedThoracoscopy | Pleural Effusion DisorderEgypt
-
Clover Biopharmaceuticals AUS Pty LtdCompletedMalignant Pleural EffusionsAustralia
-
JemincareRecruitingMalignant Pleural Effusions (Mpe)China
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPleural NeoplasmUnited States
-
Johns Hopkins UniversityEnrolling by invitationMalignant Pleural EffusionsUnited States
-
Eastern Regional Medical CenterRecruitingLoculated or Non-draining Malignant Pleural EffusionsUnited States
-
Assiut UniversityNot yet recruitingMalignant Pleural EffusionEgypt
-
JemincareZhejiang Hangyu Pharmaceutical Co., LtdRecruitingMalignant Pleural EffusionChina
Clinical Trials on semirigid thoracoscopy
-
All India Institute of Medical Sciences, New DelhiCompletedPleural EffusionIndia
-
China-Japan Friendship HospitalNot yet recruiting
-
Marmara UniversityUnknown
-
Naestved HospitalOdense University Hospital; Zealand University Hospital; Rigshospitalet, Denmark and other collaboratorsTerminated
-
China-Japan Friendship HospitalNot yet recruitingPleural Effusion Disorder
-
Alexandria UniversityCompleted
-
Assiut UniversityUnknown
-
Singapore General HospitalCompletedMalignant Pleural EffusionsSingapore
-
China-Japan Friendship HospitalNot yet recruitingPleural Effusion, Malignant | Pleural Effusion | Fibrinous Pleuritis